Arkolith/Insider Trading/SGP/Form 4

Walker Paul Edward

10% OwnerSpyGlass Pharma, Inc. (SGP) · full profile →Form 4 · filed Feb 11, 2026
Net Buying
Open-Market Buys
$15.0M
Open-Market Sells
$0
Net Open-Market Flow
$15.0M
Transactions
13
7 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)955K——955K
Feb 9, 2026Conversion(C)1.6M——1.6M
Feb 9, 2026Conversion(C)402K——1.4M
Feb 9, 2026Conversion(C)1.4M——3.0M
Feb 9, 2026Conversion(C)1.4M——4.4M
Feb 9, 2026Conversion(C)738K——5.1M
Feb 9, 2026Buy(P)938K$16.00$15.0M6.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2026Conversion(C)1.6M——0
Feb 9, 2026Conversion(C)1.4M——0
Feb 9, 2026Conversion(C)1.4M——0
Feb 9, 2026Conversion(C)738K——0
Feb 9, 2026Conversion(C)955K——0
Feb 9, 2026Conversion(C)402K——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-046662) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML